Experimental pancreatic cancer pill helps improve survival in late-stage study

AFP / France 24
by FRANCE24
April 15, 2026
2 views
2 min read

Quick Insights

The Bottom Line

An experimental oral drug, daraxonrasib, improved survival for pancreatic cancer patients in a late-stage trial.

How This Affects You

If you or a loved one has pancreatic cancer, this experimental drug showed a median overall survival of 13.2 months, nearly double the standard treatment.

AI Summary

Revolution Medicines announced that its experimental oral drug, daraxonrasib, improved survival for patients with pancreatic cancer in a late-stage trial. Patients receiving the once-daily pill demonstrated a median overall survival of 13.2 months, significantly longer than the 6.7 months for those on standard intravenous cytotoxic chemotherapy. This represents a substantial improvement in survival without disease worsening for a cancer known for its aggressive nature and poor prognosis. The positive results from this keenly anticipated study could offer a new treatment option for patients battling late-stage pancreatic cancer.

Following this story?

Get notified when new coverage appears

Should this be getting more attention?

You Might Have Missed

Related stories from different sources and perspectives

Pancreatic cancer pill shown to nearly double overall survival time, drug company says
Health

Pancreatic cancer pill shown to nearly double overall survival time, drug company says

The company reports the drug showed “clinically meaningful improvements” in overall survival.

The HillApr 14
How Merck keeps prices for its blockbuster cancer drug sky high - USA Today
Corporate

How Merck keeps prices for its blockbuster cancer drug sky high - USA Today

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxONjV1Y0pSV3Z6ZGtNbDVuNXIxWmJpRmFGODRZa1V0a04wRDhuRU5qQk1qc2ZDNHZrdS12Y2xlVjNKLWV5OVU4RDFWSmRFQzAtUmU2ZWZxREtNaERtUkFUdWxYQ1BNQTh5N0c2cDZYRE1ETzV0LURRalBJdlVHV0pGRjhoSVpncnQ2WU1hckF5dzJJZVdsbVZkLUlUVFg4VTROMDFuM3c5UnB6dWJXWV9MOGZSdW1fdw?oc=5" target="_blank">How Merck keeps prices for its blockbuster cancer drug sky high</a>&nbsp;&nbsp;<font color="#6f6f6f">USA Today</font>

USA TodayApr 14
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide
Corporate

How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide

The pharmaceutical giant has built a fortress of patents, traded in secrecy and relentlessly lobbied to guard its revenue kingpin Keytruda.

ICIJApr 13
Younger adult colon cancer deaths are concentrated in people with less education, study says - AP News
Health

Younger adult colon cancer deaths are concentrated in people with less education, study says - AP News

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOVjhWUnhqSGtNQThFYUdmX2tJQ0RKTEdlZE4xYTRxZXU5RVBmQmxieFpUUk1raFF4RlpybzhlckRpNVZrRWFTTGFrQkRzeWRGaFR6eDZELVpDWWtvTW1TMkszLVZ2RFNJb1Y4MUVOR2NkMEs0VnphVkF4d1Z1ci1JWnZEeUR5X29OcFpyVUc1ejRXWG5FRlJZ?oc=5" target="_blank">Younger adult colon cancer deaths are concentrated in people with less education, study says</a>&nbsp;&nbsp;<font color="#6f6f6f">AP News</font>

AP NewsApr 16
Lilly's obesity pill draws 1,390 US prescriptions in launch week - Reuters
Health

Lilly's obesity pill draws 1,390 US prescriptions in launch week - Reuters

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPRHBiZGRTeWV1Tl85REtGNVA5TlhRUGhYTnVZckczQnlzdTVIb3lxUnJfYnFDWjRkbk5UWVAwZG1tdExvTjd2OWNaNGFwVkx2aTVIcEFBVWJRZTJ6T2J3dWpyZG1rcFlONk1JQUM3ekl3azNXby1vY0VWVTRUa1A4RGlZR3RMRFFDVVNhSG9zUnR4SjBRZ0p3bXRaU0FGTGx2WFB0aE1B?oc=5" target="_blank">Lilly's obesity pill draws 1,390 US prescriptions in launch week</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

ReutersApr 17
Washington DC’s 240 million-gallon sewage spill is a symptom of nationwide trouble
Environment

Washington DC’s 240 million-gallon sewage spill is a symptom of nationwide trouble

The largest sewage spill in US history wasn’t the first, and it won’t be the last.

The ConversationApr 16
Read Next
Texas Medical Board Sanctions Three Doctors for Delayed Care That Led to the Deaths of Two Pregnant Women
Health

Texas Medical Board Sanctions Three Doctors for Delayed Care That Led to the Deaths of Two Pregnant Women

The post Texas Medical Board Sanctions Three Doctors for Delayed Care That Led to the Deaths of Two Pregnant Women appeared first on ProPublica .

Continue reading

Did this story change how you see things?

Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.

Share this story

Get the daily digest

Save for later

The Verity Ledger curates verified investigative journalism from trusted sources only.

See our sources